Symptoms of rheumatoid arthritis are a result of the body's immune system attacking its own tissues, causing inflammation. The lining around the joints, as well as other parts of your body, is affected. This can lead to joint damage, pain and disability.
Treatments for RA are often designed to slow or stop joint inflammation, prevent bone loss and keep you moving without pain. These include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs).
By reducing inflammation, NSAIDs can help relieve your pain. These pills are available over-the counter or on prescription, with prescription versions having a higher dosage and requiring fewer doses per day. The pills can also increase blood pressure which increases your risk of stroke and heart attack.
Steroids can be given as a shot into an inflamed joint or taken by mouth. These steroids reduce pain and inflammation, but can also cause weight gain, muscle weakness and bone loss. These drugs can increase your blood pressure, worsen diabetes and increase your risk for infection.
Methotrexate also works as an anti-inflammatory and can stop or slow joint damage. You can take methotrexate alone or in combination therapy along with other drugs including hydroxychloroquine (HCQ), leflunomide (LF), or sulfasalazine.
DMARDs suppress your immune response. They can also slow down RA's progression and reduce symptoms, such as swelling, stiffness and tiredness. They come in a wide range of forms.
Sativex for rheumatoid arthritis is a cannabis-based medicine that contains delta-9-tetrahydrocannabinol (THC) and cannabidol (CBD). Patients with RA have reported improved sleep, reduced inflammation, and less pain in clinical studies.
THC and CBD interact at the CB1-receptors in your mind to produce feelings like relaxation and euphoria. It has also been proven that they inhibit the activity neuropeptides which trigger the symptoms associated with rheumatoid arthritis.
You can also use them to control neuropathic or inflammatory pain. A study of 58 RA patient found that a Sativex single dose or the equivalent of oral medical marijuana improved stiffness as well as pain and sleep in RA.
This was the very first study that compared a cannabis-based medication with an anti-inflammatory for treating rheumatoid Arthritis. It has also been shown to improve pain and other symptoms in multiple sclerosis patients.
Sativex is a medication that can be administered by sublingual spray, or directly in the mouth. It contains a combination of THC and CBD, which are both natural compounds in marijuana.
It's made by GW Pharmaceuticals. A company that manufactures medications for multiple sclerosis (MS) and other illnesses. It's available in Europe, the United States and Canada.
The Sativex spray contains THC and CBD, which are naturally occurring compounds in marijuana. The spray has been shown to also have anti-inflammatory effects and can stop the progression of RA.
FAQ
What's the future for the CBD industry?
The future is bright for the CBD industry. It is easy to see why this sector is so popular. It's easy to see why this market is growing exponentially, with CBD products generating over $1 billion in global sales.
Statista estimates that worldwide cannabidiol sales will hit $22.4 billion by 2019. This is an almost 200% increase from 2018!
A compound annual growth rate (CAGR) of 22.5% is predicted for the CBD market, which will translate into nearly $6.8 Billion in revenue by 2022.
This is good news for both companies that want to enter the CBD market and those who are already in this sector. The CBD market is still young and may face challenges.
Is there any evidence CBD has anxiety-reducing properties?
CBD oil is an effective treatment for anxiety. This happens because it interacts to certain brain receptors called CB1 (and CB2), respectively. The endocannabinoid system regulates mood and stress responses.
When we feel anxious, our bodies release chemicals that activate the CB1 receptor. When activated, this receptor sends signals to the amygdala, which is responsible for emotional processing.
If the CB1 receptor becomes blocked, the brain doesn't get the signal to express emotions. CBD users report less negative feelings.
2017 research showed that CBD has been shown to reduce anxiety in those suffering from socialphobia. Another study found that CBD reduced symptoms of PTSD.
An 2018 review found that CBD is anxiolytic and can help with generalized anxiety disorder.
Another review suggested that CBD might also reduce panic attacks.
However, multiple studies have shown that CBD does increase anxiety in mice.
Researchers believe this discrepancy in animal data and human data could be due to differences between humans and dogs' responses to CBD.
CBD does not have any safety data. Most experts agree that CBD can be safely used when it is directed.
What is the size of the global CBD market?
According to Euromonitor International, the global CBD market was worth $US 3.5 Billion in 2015. This represents an increase of over 10% from 2014.
The report projects that this figure will reach $US6.4 billion by 2020. This represents an average annual growth rate 12%.
CBD products will make up around half of all products derived from hemp by 2020.
This includes CBD oils as well as other CBD products, such food, beverages and cosmetics.
What are the best CBD brands available?
We've handpicked these top five CBD brands based on quality, reliability, and value.
They provide high-quality CBD oils that have less than 0.2% THC.
We also recommend checking out our list of the best CBD sellers worldwide.
Where can I get CBD products?
CBD can be purchased online or in local shops. Online retailers offer better deals. Many websites sell CBD products containing industrial hemp.
You can shop locally if you prefer to buy CBD products from brick-and-mortar stores.
A lot of states have passed laws that allow consumers to purchase CBD products without the need for a prescription. CBD products can be purchased at your local pharmacy in some states if you are one of them.
You may even be able to get CBD products delivered directly to your door.
Statistics
- The inhibition of FAAH is predicted to lead to an increase in brain and plasma concentrations of AEA, which acts as a partial agonist at CB1R and CB2R, thereby increasing endocannabinoid tone [92, 110]. (ncbi.nlm.nih.gov)
- CBD seems unlikely to directly influence sleep in healthy humans [115] (and maybe “sleep-promoting” in those with certain comorbid conditions) (ncbi.nlm.nih.gov)
- however, one study also found that these effects were virtually abolished when the original media (a nutrient broth agar) was replaced with one containing 5% blood (increasing the minimum concentration to ~160 μM CBD) [179]. (ncbi.nlm.nih.gov)
- While the primary injury may not be treatable, interventions that attenuate secondary sequelae are likely to be of benefit [203].Only one study (ncbi.nlm.nih.gov)
- HR −16 mmHg; 95% CI −26, −6; I2 = 92%) (ncbi.nlm.nih.gov)
External Links
How To
What are the issues that the CBD industry faces?
The market for CBD products is expanding at an astounding rate. However, there are still many challenges facing businesses looking to enter this space. These include a lack consumer awareness, high-cost entry, limited access capital and regulatory uncertainty.
Many people don't know much about CBD or how it works. This means that consumers are unable make informed decisions about purchasing CBD products.
CBD companies are heavily dependent on word-of–mouth marketing. This is costly, as it requires advertising and the hiring of staff to promote their brand.
Another issue facing new entrants into the CBD industry is the high cost of production. It is very expensive to obtain the raw materials required for CBD products. CBD oil can only be made if hemp is grown in the right climate and soil conditions.
Grow enough hemp to produce CBD oil requires approximately $1,000 per annum. This means that many small farmers cannot afford the cost of starting.
The lack of capital access is another obstacle new entrants to the CBD market face. Due to the stigma surrounding the industry, banks discourage many people who wish to start businesses.
Last but not least, there is regulatory uncertainty regarding the sale and distribution of CBD products. There are currently not clear guidelines as to how CBD products should marketing.
Although states have passed laws restricting CBD products sales, these policies are not yet national.
So far, only two states - Maine and Nevada - have legalized recreational marijuana.
However, some states like Massachusetts and Michigan are considering similar measures.
These changes could result in increased competition between CBD manufacturer.
These factors lead to many entrepreneurs choosing to work from their home instead of starting a physical company.